However, tumor cells tend to be self-origin and are inherently not very immunogenic, hence failure to be recognized by APCs is generally the major obstacle for cancer immunotherapy including PD-1 blockade therapy [27, 31]. This evidence concerns the gene PDCD1 and cancer.